Negative allosteric modulator activity at human CB1R expressed in CHO-K1 cells assessed as inhibition of CP55,940-induced beta-arrestin recruitment preincubated for 30 mins followed by CP55,940 addition measured for 90 mins by PathHunter assay
Negative allosteric modulator activity at human CB1R expressed in CHO-K1 cells assessed as inhibition of CP55,940-induced beta-arrestin recruitment preincubated for 30 mins followed by CP55,940 addition measured for 90 mins by PathHunter assay relative to control
Negative allosteric modulator activity at human CB1R expressed in CHO-K1 cells assessed as effect on CP55,940-induced inhibition of forskolin-induced cAMP accumulation preincubated for 30 mins followed by CP55,940 addition measured for 30 mins by HitHunter assay
Negative allosteric modulator activity at human CB1R expressed in CHO-K1 cells assessed as effect on CP55,940-induced inhibition of forskolin-induced cAMP accumulation preincubated for 30 mins followed by CP55,940 addition measured for 30 mins by HitHunter assay relative to control
Negative allosteric modulator activity at CB1R in mouse brain membranes assessed as inhibition of CP55,940-induced [35S]GTPgammaS binding at 100 nM and 1 uM preincubated for 60 mins prior to [35S]GTPgammaS addition by liquid scintillation spectrometric analysis
Agonist activity at CB1R in mouse brain membranes assessed as [35S]GTPgammaS binding at 100 nM and 1 uM preincubated for 60 mins prior to [35S]GTPgammaS addition by liquid scintillation spectrometric analysis
Inverse agonist activity at CB1R in mouse brain membranes assessed as [35S]GTPgammaS binding at 100 nM and 1 uM preincubated for 60 mins prior to [35S]GTPgammaS addition by liquid scintillation spectrometric analysis
Agonist activity at human CB1R expressed in CHO-K1 cells assessed as inhibition of CP55,940-induced [35S]GTPgammaS binding up to 1 uM preincubated for 60 mins prior to [35S]GTPgammaS addition by liquid scintillation spectrometric analysis
Inverse agonist activity at human CB1R expressed in CHO-K1 cells assessed as inhibition [35S]GTPgammaS binding up to 1 uM preincubated for 60 mins prior to [35S]GTPgammaS addition by liquid scintillation spectrometric analysis
Positive allosteric modulator activity at human CB1R expressed in CHO cells assessed as enhanced binding of [3H]CP55,940 after 60 mins by liquid scintillation spectrometric analysis
Negative allosteric modulator activity at CB1R in mouse brain membranes assessed as Emax for CP55,940-induced [35S]GTPgammaS binding at 100 nM preincubated for 60 mins prior to [35S]GTPgammaS addition by liquid scintillation spectrometric analysis relative to control (Rvb = 94.3%)
Negative allosteric modulator activity at CB1R in mouse brain membranes assessed as Emax for CP55,940-induced [35S]GTPgammaS binding at 1 uM preincubated for 60 mins prior to [35S]GTPgammaS addition by liquid scintillation spectrometric analysis relative to control (Rvb = 94.3%)
Activity at CB1R in mouse brain membranes assessed as inhibition of CP55,940-induced [35S]GTPgammaS binding preincubated for 60 mins prior to [35S]GTPgammaS addition by liquid scintillation spectrometric analysis
Activity at CB1R in mouse brain membranes assessed as inhibition of CP55,940-induced [35S]GTPgammaS binding at 100 nM and 1 uM preincubated for 60 mins prior to [35S]GTPgammaS addition by liquid scintillation spectrometric analysis relative to control
Positive allosteric modulator activity at human CB1R expressed in CHO cells assessed as enhanced binding of [3H]CP55,940 after 60 mins by liquid scintillation spectrometric analysis relative to control
Positive allosteric modulator activity at human CB1R expressed in HEK293 cell membranes assessed as enhanced binding of [3H]CP55,940 at 500 nM by liquid scintillation spectrometric analysis
Positive allosteric modulator activity at human CB1R expressed in HEK293 cell membranes assessed as enhanced specific binding of [3H]CP55,940 at 500 nM pre-incubated for 60 mins before [3H]CP55,940 addition followed by drug wash-out by liquid scintillation spectrometric-based saturation binding assay
Activity at human CB1R expressed in HEK293 cell membranes assessed as reduction in binding of [3H]CP55,940 at 500 nM after 90 to 120 mins by liquid scintillation spectrometric analysis